Absci (ABSI|$362.3M) - 2025 Q2 Earnings Analysis скачать в хорошем качестве

Absci (ABSI|$362.3M) - 2025 Q2 Earnings Analysis

#ABSI Absci 2025 Q2 Earnings: Absci reported a net loss and lower-than-expected EPS in Q2 2025, but strategic partnerships and pipeline advancements highlight future growth potential. Revenue: $0.6 million Adj. EPS: -0.24 vs. forecast -0.19 (3 analysts) Net Loss: $30.6 million Cash Raised: $64M in July 2025 "The past few months have been a period of strong execution for Absci, and we are positioned to build on this momentum," said Sean McClain, Founder and CEO. If you enjoyed this video, please like, subscribe, and hit the notification bell to stay updated with our latest stock analysis and market insights. Leave a comment below with your thoughts on the video, and any other stocks you'd like us to cover. Check out our latest videos on more earnings: #UAMY United States Antimony Corporation 2025 Q2 Earnings:    • United States Antimony Corporation (UAMY|$...   #TBPH Theravance Biopharma 2025 Q2 Earnings:    • Theravance Biopharma (TBPH|$576.0M) - 2025...   #VINP Vinci Compass 2025 Q2 Earnings:    • Vinci Compass (VINP|$604.0M) - 2025 Q2 Ear...   #ZVRA Zevra 2025 Q2 Earnings:    • Zevra (ZVRA|$657.2M) - 2025 Q2 Earnings An...   #STOK Stoke Therapeutics 2025 Q2 Earnings:    • Stoke Therapeutics (STOK|$715.2M) - 2025 Q...